Welcome to our dedicated page for Marimed news (Ticker: MRMD), a resource for investors and traders seeking the latest updates and insights on Marimed stock.
MariMed Inc. (MRMD) generates frequent news as a multi-state cannabis operator and cannabis consumer packaged goods company focused on branded products, facility operations, and regulatory developments. Its releases cover both corporate performance and brand-level activity across cultivation, production, and retail channels.
On this page, readers can follow MariMed’s earnings announcements, where the company discusses revenue trends, gross margins, net income or loss, and non-GAAP measures such as Adjusted EBITDA. These updates often include commentary on wholesale and retail performance, as well as progress on what management calls its "Expand the Brand" strategy to grow top-selling cannabis brands.
MariMed’s news flow also highlights product and brand developments. Examples include new limited-edition Betty’s Eddies™ fruit chews, extensions to the Nature’s Heritage™ product line, and initiatives for Vibations™ and InHouse™. The company reports on licensing and managed services agreements that bring its brands into additional states, as well as strategic decisions such as exiting specific markets after operational reviews.
In addition, MariMed issues releases on community and veteran-focused initiatives tied to its Thrive dispensaries and brands, along with commentary on major policy changes affecting cannabis, such as the rescheduling of cannabis at the federal level. Investors and observers can use this news feed to monitor how MariMed communicates its strategy, brand expansion, financial performance, and responses to regulatory and market changes over time.
MariMed (CSE: MRMD, OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, has scheduled its first quarter 2025 earnings release for May 7, 2025 after market close.
The company will host a conference call to discuss the financial results on May 8, 2025 at 8:00 a.m. EDT. Investors can access the webcast through MariMed's Investor Relations website, where a playback will also be available after the call.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Crandall will oversee the company's commercial strategy, including Sales, Marketing, Product Development, and Retail Operations.
Crandall previously served as MariMed's Chief Revenue Officer since July 2022 and held positions as Chief Products Officer and SVP, Sales. He entered the cannabis industry in 2014 as co-creator of Betty's Eddies™, a cannabis-infused chews brand that was later acquired by MariMed. Before joining MariMed in 2018, he held executive positions in cybersecurity and software corporations, including RSA Security and EMC2.
MariMed Inc. (MRMD) has expanded its Betty's Eddies™ product line with the launch of Betty's Caramelt Away, a new THC and CBG-infused caramel chew. The product debuts on National Caramel Day (April 5) and is currently available in Massachusetts cannabis retailers, with planned expansion into other MariMed wholesale markets.
The new caramel chews are infused with full-spectrum hash and CBG, designed to create a mellow experience. Betty's Eddies currently holds the position of most popular edible brand in several core markets including Massachusetts, Maryland, and Delaware.
This addition joins Betty's existing product portfolio which includes:
- Bedtime Betty's for sleep
- Take It Easy Eddies for stress relief
- Go Betty Go for energy
- Ache Away Eddies for pain relief
- Smashin' Passion for sexual wellness
- Betty Good Times for recreational use
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) has launched its Nature's Heritage™ brand of cannabis flower, pre-rolls, and vapes in Illinois, marking the brand's first entry into the state. The launch follows the opening of MariMed's Mt. Vernon cultivation facility in late 2024.
The products are now available at MariMed's five branded dispensaries and select retailers across Illinois. This completes the company's brand portfolio in the state, following the late 2023 introduction of other products including Betty's Eddies™, Bubby's Baked™, InHouse™, and Vibations™. MariMed has achieved significant market penetration, with its products now available in approximately 82% of Illinois dispensaries.
MariMed Inc. (MRMD) has announced its financial results for Q4 and full year 2024, reporting record revenues and improved adjusted EBITDA. The company's wholesale revenue grew by 29% annually, with its brands gaining market share across core markets. Betty's Eddies™ fruit chews lead as the top-selling edible in Massachusetts and Maryland.
Key operational highlights include the launch of growing operations at a new cultivation facility in Mt. Vernon, Illinois in October, and the commencement of manufacturing operations in Missouri with wholesale distribution beginning in December 2024. In March 2025, Delaware approved MariMed as the owner of First State Compassion Center (FSCC), the state's leading vertical cannabis operator.
The company's 2025 growth strategy focuses on leveraging completed revenue-generating assets, expanding wholesale presence in Illinois, Missouri, and Maryland, consolidating Delaware operations as the state prepares for adult-use sales, and pursuing strategic M&A opportunities.
MariMed Inc. (CSE: MRMD) has completed its acquisition of First State Compassion Center (FSCC), Delaware's leading cannabis operator. The acquisition includes FSCC's cultivation and processing facilities, along with two dispensaries, strengthening MariMed's vertical operations.
The deal follows a July 2023 Omnibus Agreement and was made possible after Delaware permitted FSCC's transition from non-profit to for-profit status. The timing aligns with Delaware's anticipated launch of adult-use cannabis sales, with the state projecting annual market growth to $215 million.
MariMed and FSCC's partnership dates back to 2014, with MariMed providing management and real estate services. FSCC currently distributes MariMed's brands in Delaware, including Betty's Eddies™ fruit chews and Vibations™ drink mix, which lead their respective categories. Nature's Heritage™ flower, introduced in spring 2024, ranks fourth among flower brands in the state.
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), a multi-state cannabis operator, has scheduled its fourth quarter and full year 2024 earnings release for March 5, 2025, after market close. The company will host a conference call to discuss the financial results on March 6, 2024, at 8:00 a.m. EST. A webcast will be available through MariMed's Investor Relations website, with a playback option provided afterward.
MariMed Inc. (CSE: MRMD, OTCQX: MRMD) has launched cannabis wholesale operations in Missouri, marking its sixth state of revenue-generating operations. The company's award-winning products, including Betty's Eddies™ fruit chews, Bubby's Baked™ confections, Vibations™ drink mixes, and InHouse™ flower, vapes, and gummies, are now available in select Missouri dispensaries. The company plans to expand distribution across the state over the coming months. MariMed will operate under a Managed Services Agreement until license transfer approval, joining its existing operations in Delaware, Illinois, Maryland, Massachusetts, and Ohio.
MariMed Inc. (OTCQX: MRMD) reported its Q3 2024 financial results with revenue of $40.6 million, up from $38.8 million in Q3 2023. The company showed year-over-year and sequential revenue growth, though faced margin pressure with GAAP gross margin declining to 41% from 43%. The wholesale business maintained over 20% year-over-year growth, while retail transactions increased driven by same-store sales and new dispensaries. The company updated its 2024 guidance, projecting revenue growth of 6-8% and adjusted EBITDA decline of 18-20%. Notable operational developments include expanded cultivation facilities in Maryland and Illinois, and new dispensary openings in Maryland and Ohio.